ОЦЕНКА ЛИПИДНОГО ПРОФИЛЯ У ПАЦИЕНТОВ С АЛКОГОЛЬНОЙ БОЛЕЗНЬЮ ПЕЧЕНИ ПОСЛЕ СТАНДАРТНОГО ЛЕЧЕНИЯ

Abstract

The success of standard therapy for alcoholic liver disease in terms of forecasting the risks of an adverse outcome is now assessed using the degree of decrease in the activity of laboratory markers of cytolysis and cholestasis. The study aims to examine a lipid profile through comparing of laboratory parameters in 28 patients aged forty to sixty with alcoholic liver disease before and after standard treatment in terms of mortality risks. When compared to the mortal risks before and after standard treatment in the group of patients with an achieved total cholesterol level of more than 5 mmol/L, the mortality risk was significantly reduced in patients with an achieved total cholesterol level of less than 5 mmol/L. It has been demonstrated that, in the presence of significant fluctuations in cholestasis indicators, a total cholesterol level in the blood serum of less than 5 mmol/L can be used as a criterion for reducing the mortality risk in patients after standard therapy for alcoholic liver disease.